For best viewing of the website please use Mozilla Firefox or Google Chrome.
Citation: Lamprini Posnakoglou, Elizabeth-Barbara Tatsi, Tania Siahanidou, Vasiliki Syriopoulou, Athanasios Michos. Genetic Variations in Human Parechovirus Type 3 in Infants with Central Nervous System Infection [J].VIROLOGICA SINICA, 2021, 36(6) : 1660-1663.  http://dx.doi.org/10.1007/s12250-021-00426-3

Genetic Variations in Human Parechovirus Type 3 in Infants with Central Nervous System Infection

  • Corresponding author: Athanasios Michos, amichos@med.uoa.gr, ORCID: 0000-0003-1745-1118
  • Received Date: 07 February 2021
    Accepted Date: 26 May 2021
    Published Date: 26 July 2021
    Available online: 01 December 2021

  • 加载中
    1. Alexandersen S, Nelson TM, Hodge J, Druce J (2017) Evolutionary and network analysis of virus sequences from infants infected with an Australian recombinant strain of human parechovirus type 3. Sci Rep 7: 3861
        doi: 10.1038/s41598-017-04145-2

    2. Benschop KS, de Vries M, Minnaar RP, Stanway G, van der Hoek L, Wolthers KC, Simmonds P (2010) Comprehensive full-length sequence analyses of human parechoviruses: diversity and recombination. J Gen Virol 91: 145–154
        doi: 10.1099/vir.0.014670-0

    3. Berk MC, Bruning AHL, van Wassenaer-Leemhuis AG, Wolthers KC, Pajkrt D (2018) Human parechovirus meningitis with adverse neurodevelopmental outcome: a case report. Pediatr Infect Dis J 37: e256–e257
        doi: 10.1097/INF.0000000000001984

    4. Britton PN, Khandaker G, Khatami A, Teutsch S, Francis S, McMullan BJ, Jones CA (2018) High prevalence of developmental concern amongst infants at 12 months following hospitalised parechovirus infection. J Paediatr Child Health 54: 289–295
        doi: 10.1111/jpc.13728

    5. Chakrabarti P, Warren C, Vincent L, Kumar Y (2018) Outcome of routine cerebrospinal fluid screening for enterovirus and human parechovirus infection among infants with sepsis-like illness or meningitis in Cornwall, UK. Eur J Pediatr 177: 1523–1529
        doi: 10.1007/s00431-018-3209-8

    6. Chamings A, Druce J, Caly L, Yoga Y, Britton PN, Macartney KK, Alexandersen S (2019) Evolutionary analysis of human parechovirus type 3 and clinical outcomes of infection during the 2017–18 Australian epidemic. Sci Rep 9: 8906
        doi: 10.1038/s41598-019-45445-z

    7. Graul S, Böttcher S, Eibach D, Krumkamp R, Käsmaier J, Adu-Sarkodie Y, May J, Tannich E, Panning M (2017) High diversity of human parechovirus including novel types in stool samples from Ghanaian children. J Clin Virol 96: 116–119
        doi: 10.1016/j.jcv.2017.10.008

    8. Habuka R, Aizawa Y, Izumita R, Domon H, Terao Y, Takihara H, Okuda S, Saitoh A (2020) Innate immune responses in serum and cerebrospinal fluid from neonates and infants infected with parechovirus-A3 or enteroviruses. J Infect Dis 222: 681–689
        doi: 10.1093/infdis/jiaa131

    9. Kadambari S, Harvala H, Simmonds P, Pollard AJ, Sadarangani M (2019) Strategies to improve detection and management of human parechovirus infection in young infants. Lancet Infect Dis 19: e51–e58
        doi: 10.1016/S1473-3099(18)30288-3

    10. Khatami A, Burrell R, McMullan BJ, Rawlinson W, Givney RC, Kok J, Alexandersen S, Jones CA, Macartney KK, Britton PN (2020) Epidemic and inter-epidemic burden of pediatric human parechovirus infection in new south wales, Australia, 2017–2018. Pediatr Infect Dis J 39: 507–511
        doi: 10.1097/INF.0000000000002615

    11. Nelson TM, Vuillermin P, Hodge J, Druce J, Williams DT, Jasrotia R, Alexandersen S (2017) An outbreak of severe infections among Australian infants caused by a novel recombinant strain of human parechovirus type 3. Sci Rep 7: 44423
        doi: 10.1038/srep44423

    12. Posnakoglou L, Siahanidou T, Syriopoulou V, Michos A (2020) Impact of cerebrospinal fluid syndromic testing in the management of children with suspected central nervous system infection. Eur J Clin Microbiol Infect Dis 39: 2379–2386
        doi: 10.1007/s10096-020-03986-6

    13. Posnakoglou L, Tatsi EB, Chatzichristou P, Siahanidou T, Kanaka-Gantenbein C, Syriopoulou V, Michos A (2021) Molecular epidemiology of enterovirus in children with central nervous system infections. Viruses 13: 100
        doi: 10.3390/v13010100

    14. Sridhar A, Karelehto E, Brouwer L, Pajkrt D, Wolthers KC (2019) Parechovirus a pathogenesis and the enigma of genotype A-3. Viruses 11: 1062
        doi: 10.3390/v11111062

    15. Vollbach S, Muller A, Drexler JF, Simon A, Drosten C, Eis-Hubinger AM, Panning M (2015) Prevalence, type and concentration of human enterovirus and parechovirus in cerebrospinal fluid samples of pediatric patients over a 10-year period: a retrospective study. Virol J 12: 199
        doi: 10.1186/s12985-015-0427-9

    16. World Health Organization (2015) Enterovirus surveillance guidelines. www.euro.who.int/__data/assets/pdf_file/0020/272810/EnterovirusSurveillanceGuidelines.pdf. Accessed 5 February 2021.

    17. Zhao X, Shi Y, Xia Y (2016) Genome analysis revealed novel genotypes and recombination of the human parechoviruses prevalent in children in eastern China. Gut Pathog 8: 52
        doi: 10.1186/s13099-016-0135-z

  • 加载中

Figures(1) / Tables(1)

Article Metrics

Article views(1488) PDF downloads(4) Cited by()

Related
Proportional views
    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Genetic Variations in Human Parechovirus Type 3 in Infants with Central Nervous System Infection

      Corresponding author: Athanasios Michos, amichos@med.uoa.gr
    • 1. Infectious Diseases and Chemotherapy Research Laboratory, First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens 11527, Greece
    • 2. First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, "Aghia Sophia" Children's Hospital, Athens 11527, Greece

    Abstract: